Lexaria Bioscience Corp. SEC filings LEXX
Lexaria Bioscience Corp. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 25, 2009. Its latest annual report, Form 10-K, was filed on Nov 28, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 13, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 13, 2026 | — |
| D | Filing | Sep 21, 2026 | — |
| EFFECT | Filing | Jan 14, 2026 | — |
| 25-NSE | Delisting notice | Jan 14, 2026 | — |
| D | Filing | Dec 19, 2025 | — |
| EFFECT | Filing | Dec 9, 2025 | — |
| EFFECT | Filing | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 5, 2025 | — |
| D | Filing | Oct 1, 2025 | — |
| EFFECT | Filing | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2025 | — |
| EFFECT | Filing | Dec 17, 2024 | — |
| EFFECT | Filing | Dec 5, 2024 | — |
| CORRESP | Letter to the SEC | Dec 3, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2024 | — |
| D | Filing | Oct 16, 2024 | — |
| EFFECT | Filing | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2024 | — |
| D | Filing | May 2, 2024 | — |
| EFFECT | Filing | Mar 20, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2024 | — |
| D | Filing | Feb 16, 2024 | — |
| EFFECT | Filing | Jan 26, 2024 | — |
| EFFECT | Filing | Dec 8, 2023 | — |
| CORRESP | Letter to the SEC | Dec 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2023 | — |
| D | Filing | Oct 4, 2023 | — |
| EFFECT | Filing | May 8, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 4, 2023 | — |
| CORRESP | Letter to the SEC | May 4, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| EFFECT | Filing | Dec 29, 2022 | — |
| EFFECT | Filing | Dec 22, 2022 | — |
| EFFECT | Filing | Feb 4, 2022 | — |
| CORRESP | Letter to the SEC | Feb 1, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2022 | — |
| EFFECT | Filing | Dec 23, 2021 | — |
| EFFECT | Filing | Dec 23, 2021 | — |
| D | Filing | Dec 20, 2021 | — |
| D | Filing | Jul 27, 2021 | — |
| EFFECT | Filing | Mar 3, 2021 | — |
| EFFECT | Filing | Jan 11, 2021 | — |
| CERT | Filing | Jan 11, 2021 | — |
| 8-A12B | Form 8-a | Jan 11, 2021 | — |
| CORRESP | Letter to the SEC | Jan 7, 2021 | — |
| CORRESP | Letter to the SEC | Jan 7, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2020 | — |
| DRS | Filing | Nov 13, 2020 | — |
| D | Filing | Jul 8, 2020 | — |
| EFFECT | Filing | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2020 | — |
| D | Filing | May 13, 2020 | — |
| D | Filing | Nov 19, 2019 | — |
| D | Filing | Nov 13, 2019 | — |
| CT ORDER | Filing | Mar 12, 2019 | — |
| D | Filing | Nov 15, 2018 | — |
| EFFECT | Filing | Mar 7, 2018 | — |
| CORRESP | Letter to the SEC | Mar 5, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2018 | — |
| CT ORDER | Filing | Nov 21, 2016 | — |
| D | Filing | Sep 13, 2016 | — |
| NT 10-K | Filing | Dec 1, 2014 | Aug 31, 2014 |
| EFFECT | Filing | Jul 2, 2012 | — |
| CORRESP | Letter to the SEC | Jun 27, 2012 | — |
| RW | Request to withdraw registration statement | May 29, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2012 | — |
| EFFECT | Filing | Aug 4, 2011 | — |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LEXX (Nasdaq)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Kelowna, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1348362
- Former names
- Lexaria Corp. (until May 11, 2016); LEXARIA CORP. (until May 11, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.